Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study

類似資料

• Regional differences in patient characteristics and outcomes during uninterrupted anticoagulation with dabigatran versus warfarin in catheter ablation of atrial fibrillation: the RE-CIRCUIT study
  著者:: Hohnloser, Stefan H., 等
  出版事項: (2019)
• Uninterrupted anticoagulation with non‐vitamin K antagonist oral anticoagulants in atrial fibrillation catheter ablation: Lessons learned from randomized trials
  著者:: Cardoso, Rhanderson, 等
  出版事項: (2018)
• Comparison of uninterrupted anticoagulation with dabigatran etexilate or warfarin in the periprocedural period for atrial fibrillation catheter ablation: Results of the Japanese subgroup of the RE‐CIRCUIT trial
  著者:: Yoshida, Yukihiko, 等
  出版事項: (2018)
• Safety of anticoagulation with uninterrupted warfarin vs. interrupted dabigatran in patients requiring an implantable cardiac device
  著者:: Madan, Shivanshu, 等
  出版事項: (2016)
• Uninterrupted dabigatran is safer than warfarin in patients undergoing ablation for atrial fibrillation
  著者:: Spartalis, Michael, 等
  出版事項: (2017)